CDK1 and breast cancer: In breast cancer cell lines and primary tumours, the ERRB2-mediated increased phosphorylation of Tyr15 of CDK1 leads to the inactivation of BAD and consequently resistance to taxol-induced apoptosis and drive cells to mitotic slippage and prolonged cell cycle arrest.